141 related articles for article (PubMed ID: 25740666)
1. Expression of IMP3 and IGF2 in giant cell tumor of spine is associated with tumor recurrence and angiogenesis.
Zhang K; Zhou M; Chen H; Wu G; Chen K; Yang H
Clin Transl Oncol; 2015 Jul; 17(7):570-5. PubMed ID: 25740666
[TBL] [Abstract][Full Text] [Related]
2. The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis.
Chen P; Wang SJ; Wang HB; Ren P; Wang XQ; Liu WG; Gu WL; Li DQ; Zhang TG; Zhou CJ
J Mol Histol; 2012 Feb; 43(1):63-70. PubMed ID: 22042095
[TBL] [Abstract][Full Text] [Related]
3. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
Jeng YM; Chang CC; Hu FC; Chou HY; Kao HL; Wang TH; Hsu HC
Hepatology; 2008 Oct; 48(4):1118-27. PubMed ID: 18802962
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma.
Chen KW; Yang HL; Lu J; Wang GL; Ji YM; Wu GZ; Zhu LF; Liu JY; Chen XQ; Gu YP
J Neurooncol; 2011 Feb; 101(3):357-63. PubMed ID: 20549300
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
Chromecki TF; Cha EK; Pummer K; Scherr DS; Tewari AK; Sun M; Fajkovic H; Roehrborn CG; Ashfaq R; Karakiewicz PI; Shariat SF
BJU Int; 2012 Jul; 110(1):63-8. PubMed ID: 22077633
[TBL] [Abstract][Full Text] [Related]
6. Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma.
Zhou M; Chen K; Yang H; Wang G; Lu J; Ji Y; Wu C; Chen C
J Neurooncol; 2014 Jan; 116(1):77-82. PubMed ID: 24135846
[TBL] [Abstract][Full Text] [Related]
7. Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma.
Chen YL; Jeng YM; Hsu HC; Lai HS; Lee PH; Lai PL; Yuan RH
Int J Surg; 2013; 11(1):85-91. PubMed ID: 23246869
[TBL] [Abstract][Full Text] [Related]
8. Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.
Suvasini R; Shruti B; Thota B; Shinde SV; Friedmann-Morvinski D; Nawaz Z; Prasanna KV; Thennarasu K; Hegde AS; Arivazhagan A; Chandramouli BA; Santosh V; Somasundaram K
J Biol Chem; 2011 Jul; 286(29):25882-90. PubMed ID: 21613208
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast.
Takizawa K; Yamamoto H; Taguchi K; Ohno S; Tokunaga E; Yamashita N; Kubo M; Nakamura M; Oda Y
Hum Pathol; 2016 Sep; 55():30-8. PubMed ID: 27137988
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer.
Sjekloča N; Tomić S; Mrklić I; Vukmirović F; Vučković L; Lovasić IB; Maras-Šimunić M
Medicine (Baltimore); 2020 Feb; 99(7):e19091. PubMed ID: 32049813
[TBL] [Abstract][Full Text] [Related]
11. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
[TBL] [Abstract][Full Text] [Related]
12. Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance.
Wang JJ; Sun XC; Hu L; Liu ZF; Yu HP; Li H; Wang SY; Wang DH
Head Neck; 2013 Dec; 35(12):1719-25. PubMed ID: 23471755
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.
Szarvas T; Tschirdewahn S; Niedworok C; Kramer G; Sevcenco S; Reis H; Shariat SF; Rübben H; vom Dorp F
Int J Cancer; 2014 Oct; 135(7):1596-604. PubMed ID: 24615121
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
[TBL] [Abstract][Full Text] [Related]
15. Expression of insulin-like growth factor-II mRNA binding protein 3 (IMP3) in osteosarcoma.
Do SI; Kim YW; Park HR; Park YK
Oncol Res; 2008; 17(6):269-72. PubMed ID: 19192721
[TBL] [Abstract][Full Text] [Related]
16. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
Martinović Ž; Kovač D; Martinović C
World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
[TBL] [Abstract][Full Text] [Related]
17. [Factors related to biologic behavior in giant cell tumor of bone].
Ran XY; Huang J; Zhang HZ; Jiang ZM; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):669-74. PubMed ID: 24433729
[TBL] [Abstract][Full Text] [Related]
18. High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer.
Szarvas T; vom Dorp F; Niedworok C; Melchior-Becker A; Fischer JW; Singer BB; Reis H; Bánkfalvi Á; Schmid KW; Romics I; Ergün S; Rübben H
BJU Int; 2012 Sep; 110(6 Pt B):E308-17. PubMed ID: 22500655
[TBL] [Abstract][Full Text] [Related]
19. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
20. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]